19 May 2013
Keywords: fda, considering, strong, warning, byetta, potential, fall-out
Article | 01 September 2008
The US Food and Drug Administration is considering strengthening the label for diabetes drug Byetta (exenatide), calling into question the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
17 May 2013
© 2013 thepharmaletter.com